Developer docs
API playgroundTry for free, no card

Search company profiles

BE Pharmaceuticals

Full company profile

uuid000s96y

Namestring
BE Pharmaceuticals
Company typeenum
Private
Founded yearint
2019
Descriptiontext

BE Pharmaceuticals is a privately held U.S. manufacturing company founded in 2019 and headquartered in Cary, North Carolina. According to its self-description, it specializes in the development of sterile vaccines and injectable products, placing it within the contract development and manufacturing (CDMO) / specialty injectables segment of the pharmaceutical supply chain. The company operates with a very small team of 1-10 employees and is led by founder and president Bill Hill.

No products, technology platforms, regulatory filings, certifications, customer relationships, partnerships, distribution channels, or pricing models have been disclosed in the available input data. The company's website (be-pharmaceuticals.com) returned only a verification/loading page at the time of data collection, and no revenue, funding history, or operating geographies have been published. As a result, the commercial model — whether BE Pharmaceuticals acts as an in-house product developer, a CDMO serving third-party clients, or an R&D-stage startup awaiting its first regulatory milestone — cannot be determined from the available evidence.

Given the combination of micro-headcount, no disclosed capital raises, and absence of any product or customer signals in the input, the company appears to be at an early, pre-commercial or pre-revenue stage. The strategic intent — whether to pursue proprietary sterile injectable development, contract manufacturing services, or vaccine partnerships — is not articulated in the available data, and any further characterization would be speculative.

Short descriptiontext

BE Pharmaceuticals is a privately held, early-stage U.S. manufacturer founded in 2019 in Cary, North Carolina, focused on developing sterile vaccines and injectable pharmaceutical products.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCary, United States
HQ citystring
Cary
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
sterile vaccine manufacturing, injectable pharmaceuticals, pharmaceutical manufacturing, vaccine development, sterile injectables
Industry4 codes
PRIMARYHLAIABAH
Generic Finished Dosage Form (FDF) Manufacturing
SECONDARYHLAAAKAB
Drug Product Fill-Finish & Aseptic Manufacturing Services
SECONDARYHLAAAJAG
Aseptic Processing, Fill-Finish & Sterile Manufacturing Tech (isolators, lyophilization interfaces)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAIABAC
Sterile Injectable Generics
NAICS code3 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Biological Product (except Diagnostic) Manufacturing325414
  • Pharmaceutical and Medicine Manufacturing32541
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Biological Products, (No Disgnostic Substances)2836
Product category
Sterile Injectable Pharmaceuticals
Social media profiles1 record
Cost components5 values
Personnel, Operations, Supply Chain, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

BE Pharmaceuticals is a manufacturing company that develops sterile vaccines and injectable pharmaceutical products. Based in Cary, United States, the company focuses on the development and production of sterile injectable products for the pharmaceutical industry.

Differentiator
Functional benefit
Problem solved
Product and service2 records
1Sterile Vaccines
CategoryPharmaceuticals
2Sterile Injectable Products
CategoryPharmaceuticals
Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeDirect peer
Description

Major biopharmaceutical CDMO offering mammalian and microbial biologics manufacturing plus sterile fill-finish, directly competing for the same sterile injectable and vaccine manufacturing contracts.

TypeDirect peer
Description

Specialty biopharmaceutical company focused on vaccines and sterile injectable countermeasures for public health threats, directly aligned with BE Pharmaceuticals' sterile vaccine manufacturing focus.

3Recipharm
TypeDirect peer
Description

European-headquartered CDMO with significant sterile injectable fill-finish capacity, offering the same kind of development-to-commercial sterile injectable services BE Pharmaceuticals targets.

TypeBroad incumbent
Description

Pfizer's contract manufacturing arm offering sterile injectable and API manufacturing services from an established global pharma network, competing for the same outsourced sterile work.

TypeDirect peer
Description

CDMO with softgel and sterile liquid/sterile injectable capabilities, serving as a mid-tier contract manufacturer comparable to where a smaller firm like BE Pharmaceuticals would compete.

TypeDirect peer
Description

Independent CDMO specializing in aseptic fill-finish of injectable biologics, with extensive expertise in sterile injectable development and commercial manufacturing — a tightly comparable peer for BE Pharmaceuticals' scope.

TypeBroad incumbent
Description

Global influenza vaccine and sterile injectable manufacturer with large-scale aseptic fill-finish operations, providing a benchmark for the scale BE Pharmaceuticals would need to reach to be a meaningful vaccine manufacturer.

TypeDirect peer
Description

Global CDMO with one of the largest sterile fill-finish and injectable drug product manufacturing networks in the world, directly comparable to BE Pharmaceuticals' stated focus on sterile injectables and vaccines.

TypeBroad incumbent
Description

Supplier of primary packaging, containment, and delivery systems for injectable drugs, serving the same sterile injectable value chain as BE Pharmaceuticals but positioned upstream in components and devices.

TypeDirect peer
Description

Baxter's contract manufacturing arm provides sterile fill-finish and injectable manufacturing services to pharma companies, a direct operational peer in the sterile injectable CDMO space.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BE Pharmaceuticals

Sterile Injectable Pharmaceuticalsbe-pharmaceuticals.com

BE Pharmaceuticals is a privately held, early-stage U.S. manufacturer founded in 2019 in Cary, North Carolina, focused on developing sterile vaccines and injectable pharmaceutical products.

What BE Pharmaceuticals does

BE Pharmaceuticals is a privately held U.S. manufacturing company founded in 2019 and headquartered in Cary, North Carolina. According to its self-description, it specializes in the development of sterile vaccines and injectable products, placing it within the contract development and manufacturing (CDMO) / specialty injectables segment of the pharmaceutical supply chain. The company operates with a very small team of 1-10 employees and is led by founder and president Bill Hill.

No products, technology platforms, regulatory filings, certifications, customer relationships, partnerships, distribution channels, or pricing models have been disclosed in the available input data. The company's website (be-pharmaceuticals.com) returned only a verification/loading page at the time of data collection, and no revenue, funding history, or operating geographies have been published. As a result, the commercial model — whether BE Pharmaceuticals acts as an in-house product developer, a CDMO serving third-party clients, or an R&D-stage startup awaiting its first regulatory milestone — cannot be determined from the available evidence.

Given the combination of micro-headcount, no disclosed capital raises, and absence of any product or customer signals in the input, the company appears to be at an early, pre-commercial or pre-revenue stage. The strategic intent — whether to pursue proprietary sterile injectable development, contract manufacturing services, or vaccine partnerships — is not articulated in the available data, and any further characterization would be speculative.

BE Pharmaceuticals firmographics

Firmographics
Name
BE Pharmaceuticals
Website
https://be-pharmaceuticals.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
51–100 employees
Short description
BE Pharmaceuticals is a privately held, early-stage U.S. manufacturer founded in 2019 in Cary, North Carolina, focused on developing sterile vaccines and injectable pharmaceutical products.
Ownership category
akta.pro rank

BE Pharmaceuticals industry classification

Industry
Product category
Sterile Injectable Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical and Medicine Manufacturing (32541)
SIC
Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAIABAH
Generic Finished Dosage Form (FDF) Manufacturing
SECONDARYHLAAAKAB
Drug Product Fill-Finish & Aseptic Manufacturing Services
SECONDARYHLAAAJAG
Aseptic Processing, Fill-Finish & Sterile Manufacturing Tech (isolators, lyophilization interfaces)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAIABAC
Sterile Injectable Generics

Keywords

  • Sterile vaccine manufacturing
  • Injectable pharmaceuticals
  • Pharmaceutical manufacturing
  • Vaccine development
  • Sterile injectables

Where BE Pharmaceuticals is headquartered

Location

Headquarters

HQ city
Cary
HQ country
United States
HQ region
North America

Markets served

BE Pharmaceuticals business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Others

BE Pharmaceuticals product offering

Product offering

Core offering

BE Pharmaceuticals is a manufacturing company that develops sterile vaccines and injectable pharmaceutical products. Based in Cary, United States, the company focuses on the development and production of sterile injectable products for the pharmaceutical industry.

Differentiator

Problem solved

Functional benefit

Products and services

  • Sterile Vaccines
  • Sterile Injectable Products

Companies that use BE Pharmaceuticals

Customer profile

Ideal customer profiles1 record

BE Pharmaceuticals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

BE Pharmaceuticals partnerships and signals

Strategic signal

Recent moves1 record

BE Pharmaceuticals competitors and assessment

Company assessment

Direct peers

  • Lonza: Major biopharmaceutical CDMO offering mammalian and microbial biologics manufacturing plus sterile fill-finish, directly competing for the same sterile injectable and vaccine manufacturing contracts.
  • Emergent BioSolutions: Specialty biopharmaceutical company focused on vaccines and sterile injectable countermeasures for public health threats, directly aligned with BE Pharmaceuticals' sterile vaccine manufacturing focus.
  • Recipharm: European-headquartered CDMO with significant sterile injectable fill-finish capacity, offering the same kind of development-to-commercial sterile injectable services BE Pharmaceuticals targets.
  • Aenova: CDMO with softgel and sterile liquid/sterile injectable capabilities, serving as a mid-tier contract manufacturer comparable to where a smaller firm like BE Pharmaceuticals would compete.
  • Vetter Pharma: Independent CDMO specializing in aseptic fill-finish of injectable biologics, with extensive expertise in sterile injectable development and commercial manufacturing — a tightly comparable peer for BE Pharmaceuticals' scope.
  • Catalent: Global CDMO with one of the largest sterile fill-finish and injectable drug product manufacturing networks in the world, directly comparable to BE Pharmaceuticals' stated focus on sterile injectables and vaccines.
  • Baxter BioPharma Solutions: Baxter's contract manufacturing arm provides sterile fill-finish and injectable manufacturing services to pharma companies, a direct operational peer in the sterile injectable CDMO space.

Broad incumbents

  • Pfizer CentreOne: Pfizer's contract manufacturing arm offering sterile injectable and API manufacturing services from an established global pharma network, competing for the same outsourced sterile work.
  • Seqirus: Global influenza vaccine and sterile injectable manufacturer with large-scale aseptic fill-finish operations, providing a benchmark for the scale BE Pharmaceuticals would need to reach to be a meaningful vaccine manufacturer.
  • West Pharmaceutical Services: Supplier of primary packaging, containment, and delivery systems for injectable drugs, serving the same sterile injectable value chain as BE Pharmaceuticals but positioned upstream in components and devices.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

BE Pharmaceuticals social profiles

Digital presence

BE Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BE Pharmaceuticals leadership team

Management profile

Number of profiles

Profiles1 record

BE Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BE Pharmaceuticals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BE Pharmaceuticals

What does BE Pharmaceuticals do?

BE Pharmaceuticals is a manufacturing company that develops sterile vaccines and injectable pharmaceutical products. Based in Cary, United States, the company focuses on the development and production of sterile injectable products for the pharmaceutical industry.

Is BE Pharmaceuticals a public or private company?

BE Pharmaceuticals is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was BE Pharmaceuticals founded?

BE Pharmaceuticals was founded in 2019. It employs 51 to 100 people.

Where is BE Pharmaceuticals based?

BE Pharmaceuticals is headquartered in Cary, United States, in the North America region.

Who are BE Pharmaceuticals's main competitors?

Direct peers on record are Lonza, Emergent BioSolutions, Recipharm, Aenova, Vetter Pharma, Catalent and Baxter BioPharma Solutions. Broad incumbents are Pfizer CentreOne, Seqirus and West Pharmaceutical Services.

Does BE Pharmaceuticals have an API?

No public API is recorded for BE Pharmaceuticals.

What industry is BE Pharmaceuticals in?

BE Pharmaceuticals's product category is Sterile Injectable Pharmaceuticals. Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing, with a secondary code of HLAAAKAB, Drug Product Fill-Finish & Aseptic Manufacturing Services. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals